Tumor-host cell interactions in the bone disease of myeloma.
about
Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effectsunveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance?Mathematical modelling of the pathogenesis of multiple myeloma-induced bone disease.Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells.Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth Arrest.Peptide Decoration of Nanovehicles to Achieve Active Targeting and Pathology-Responsive Cellular Uptake for Bone Metastasis Chemotherapy.Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblastMultiple myeloma in the marrow: pathogenesis and treatments.A virtual approach to evaluate therapies for management of multiple myeloma induced bone diseaseCx43 expressed on bone marrow stromal cells plays an essential role in multiple myeloma cell survival and drug resistanceContributions of the host microenvironment to cancer-induced bone disease.Genes associate with abnormal bone cell activity in bone metastasis.Myeloma Propagating Cells, Drug Resistance and Relapse.Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity.Emerging treatment approaches for myeloma-related bone disease.Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.Impact of connexin 43 coupling on survival and migration of multiple myeloma cells.Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential.Premature loss of bone remodeling compartment canopies is associated with deficient bone formation: A study of healthy individuals and patients with cushing's syndromeMultiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator EventImproving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles
P2860
Q28730433-A087356D-BB2B-4E91-93C9-A734D9A3D4FCQ34718186-A4078BC9-97E4-4D59-8B48-0BEDB378E4F3Q34806153-FB85ED85-3823-4DAD-85B2-05FAB4978993Q34879042-5C497EA4-5BAC-4F08-9D8A-6CE6F237AF8EQ35585973-18F01191-802A-4619-918D-8B58E283E1DFQ35649604-11F72820-88DA-4306-9C84-0B4C0D58873CQ35737342-D1038573-B890-4E91-852E-912085346D70Q35899430-BC4D694E-AB67-4818-9AA7-4E783818DC3CQ36086488-8C9BA79B-38DD-453D-8226-4211E7D87BEAQ36725401-E4253978-E60A-409D-88B8-3D95E3878298Q37185494-2E1B1DD2-326A-43B5-8C4E-15978EFB5ED3Q37549419-4C6434C1-320E-4558-B340-603B909D9271Q37663962-C2A98488-8FBB-461E-9DB5-5EE5ACF0C7EAQ38019409-30F4E8B2-3F23-4DC1-ACCE-787CABE5D41BQ38572771-8C632916-A1C4-414C-B0EB-5B266B109F5FQ39020389-4196C909-38CE-44AA-8AF5-96CD4BB533C9Q39024879-DE1D5F99-99C4-4FB7-B7DE-0D2B3EF1E7ABQ39090721-85946E24-5174-4E4D-B340-10EE045CE7D8Q42288514-40435850-68D3-415F-8F6C-FB93A9A4D211Q47358056-706B5C45-AA10-4892-A453-9A8568E72159Q54956715-223D1615-B2A9-4F25-A6FD-6A77ABA8C5F3Q57566244-978FF0AF-EA2D-4925-9F01-BED1EB1570B8Q58754109-EB65E3EF-106B-4060-962A-3ADDABB1CEA7Q58802310-C4314C27-59D6-4281-AACE-F4635E1D14E6
P2860
Tumor-host cell interactions in the bone disease of myeloma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-host cell interactions in the bone disease of myeloma.
@en
Tumor-host cell interactions in the bone disease of myeloma.
@nl
type
label
Tumor-host cell interactions in the bone disease of myeloma.
@en
Tumor-host cell interactions in the bone disease of myeloma.
@nl
prefLabel
Tumor-host cell interactions in the bone disease of myeloma.
@en
Tumor-host cell interactions in the bone disease of myeloma.
@nl
P2093
P2860
P1433
P1476
Tumor-host cell interactions in the bone disease of myeloma.
@en
P2093
Claire M Edwards
Jessica A Fowler
Peter I Croucher
P2860
P304
P356
10.1016/J.BONE.2010.06.029
P577
2010-07-13T00:00:00Z